1. Home
  2. SYBX vs QMMM Comparison

SYBX vs QMMM Comparison

Compare SYBX & QMMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • QMMM
  • Stock Information
  • Founded
  • SYBX N/A
  • QMMM 2005
  • Country
  • SYBX United States
  • QMMM Hong Kong
  • Employees
  • SYBX N/A
  • QMMM N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • QMMM
  • Sector
  • SYBX Health Care
  • QMMM
  • Exchange
  • SYBX Nasdaq
  • QMMM NYSE
  • Market Cap
  • SYBX 16.5M
  • QMMM 13.3M
  • IPO Year
  • SYBX N/A
  • QMMM 2024
  • Fundamental
  • Price
  • SYBX $1.20
  • QMMM $0.93
  • Analyst Decision
  • SYBX
  • QMMM
  • Analyst Count
  • SYBX 0
  • QMMM 0
  • Target Price
  • SYBX N/A
  • QMMM N/A
  • AVG Volume (30 Days)
  • SYBX 6.3K
  • QMMM 1.1M
  • Earning Date
  • SYBX 03-06-2025
  • QMMM 04-08-2025
  • Dividend Yield
  • SYBX N/A
  • QMMM N/A
  • EPS Growth
  • SYBX N/A
  • QMMM N/A
  • EPS
  • SYBX N/A
  • QMMM N/A
  • Revenue
  • SYBX $8,000.00
  • QMMM $2,698,229.00
  • Revenue This Year
  • SYBX N/A
  • QMMM N/A
  • Revenue Next Year
  • SYBX N/A
  • QMMM N/A
  • P/E Ratio
  • SYBX N/A
  • QMMM N/A
  • Revenue Growth
  • SYBX N/A
  • QMMM N/A
  • 52 Week Low
  • SYBX $1.15
  • QMMM $0.54
  • 52 Week High
  • SYBX $1.96
  • QMMM $13.00
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 34.47
  • QMMM N/A
  • Support Level
  • SYBX $1.27
  • QMMM N/A
  • Resistance Level
  • SYBX $1.32
  • QMMM N/A
  • Average True Range (ATR)
  • SYBX 0.05
  • QMMM 0.00
  • MACD
  • SYBX -0.01
  • QMMM 0.00
  • Stochastic Oscillator
  • SYBX 17.81
  • QMMM 0.00

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About QMMM QMMM HOLDINGS LIMITED

QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly owned subsidiaries: ManyMany Creations and Quantum Matrix. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.

Share on Social Networks: